G
Monte Rosa Therapeutics, Inc.
GLUE · NASDAQ · Healthcare · 1.3B
Closing price
$10.30
-0.19% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.9×
Enterprise value / EBITDAEV/EBITDA
-18.6×
Free cash flow yieldFCF yield
-4.1%
Return on equityROE
-16.6%
Operating margin
-43.8%
Net debt / EBITDAbalance-sheet strength
2.9×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.